David Lock. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabHumansLiability, LegalMalpractice/legislation & jurisprudenceOff-Label Use/legislation & jurisprudenceRanibizumabState Medicine/legislation & jurisprudenceUnited KingdomWet Macular Degeneration/drug therapy
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabRanibizumab
Year: 2015 PMID: 25834023 DOI: 10.1136/bmj.h1377
Source DB: PubMed Journal: BMJ ISSN: 0959-8138